Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Sources
pmc.ncbi.nlm.nih.gov shapes more of what AI says about NULISA than any other source, at 29% of its citations.
broadclinicallabs.org · precisionformedicine.com · pubmed.ncbi.nlm.nih.gov · quanterix.com
The market map
Biopharma Research Platforms and Services →Where AI ranks NULISA
Excerpts where NULISA appeared in the AI's answer

NULISA™ (Nucleic Acid Linked Immuno-Sandwich Assay): A newer technology frequently benchmarked against Olink and MSD for low-volume, high-multiplexing capabilities in CNS and inflammatory studies.

NULISA (Alamar Biosciences) and Olink are preferred when dealing with very low sample volumes